Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 29 entries
Sorted by: Best Match Show Resources per page
What do we do when attenuation of cerebral function goes hand in hand with maximally effective surgery?.

Acta neurochirurgica

Brennum J, Maier CM, Almdal K, Engelmann CM, Gjerris M.
PMID: 25666109
Acta Neurochir (Wien). 2015 May;157(5):811-2. doi: 10.1007/s00701-015-2364-1. Epub 2015 Feb 11.

No abstract available.

Cite
Brennum J, Maier CM, Almdal K, et al. What do we do when attenuation of cerebral function goes hand in hand with maximally effective surgery?. Acta Neurochir (Wien). 2015;157(5):811-2doi: 10.1007/s00701-015-2364-1.
Brennum, J., Maier, C. M., Almdal, K., Engelmann, C. M., & Gjerris, M. (2015). What do we do when attenuation of cerebral function goes hand in hand with maximally effective surgery?. Acta neurochirurgica, 157(5), 811-2. https://doi.org/10.1007/s00701-015-2364-1
Brennum, Jannick, et al. "What do we do when attenuation of cerebral function goes hand in hand with maximally effective surgery?." Acta neurochirurgica vol. 157,5 (2015): 811-2. doi: https://doi.org/10.1007/s00701-015-2364-1
Brennum J, Maier CM, Almdal K, Engelmann CM, Gjerris M. What do we do when attenuation of cerebral function goes hand in hand with maximally effective surgery?. Acta Neurochir (Wien). 2015 May;157(5):811-2. doi: 10.1007/s00701-015-2364-1. Epub 2015 Feb 11. PMID: 25666109.
Copy Download .nbib Format: NLM
Editorial: standard neuropsychological assessments in neurosurgery.

Acta neurochirurgica

Forchhammer HB, Brennum J.
PMID: 26126761
Acta Neurochir (Wien). 2015 Sep;157(9):1459-60. doi: 10.1007/s00701-015-2483-8. Epub 2015 Jul 01.

No abstract available.

Cite
Forchhammer HB, Brennum J. Editorial: standard neuropsychological assessments in neurosurgery. Acta Neurochir (Wien). 2015;157(9):1459-60doi: 10.1007/s00701-015-2483-8.
Forchhammer, H. B., & Brennum, J. (2015). Editorial: standard neuropsychological assessments in neurosurgery. Acta neurochirurgica, 157(9), 1459-60. https://doi.org/10.1007/s00701-015-2483-8
Forchhammer, Hysse Birgitte, and Brennum, Jannick. "Editorial: standard neuropsychological assessments in neurosurgery." Acta neurochirurgica vol. 157,9 (2015): 1459-60. doi: https://doi.org/10.1007/s00701-015-2483-8
Forchhammer HB, Brennum J. Editorial: standard neuropsychological assessments in neurosurgery. Acta Neurochir (Wien). 2015 Sep;157(9):1459-60. doi: 10.1007/s00701-015-2483-8. Epub 2015 Jul 01. PMID: 26126761.
Copy Download .nbib Format: NLM
Warmed-over flavour in porcine meat - a combined spectroscopic, sensory and chemometric study.

Meat science

Brøndum J, Byrne DV, Bak LS, Bertelsen G, Engelsen SB.
PMID: 22063716
Meat Sci. 2000 Jan;54(1):83-95. doi: 10.1016/s0309-1740(99)00085-6.

The effectiveness of applying rapid spectral techniques in the prediction of meat quality in relation to pre-slaughter stress and warmed-over flavour (WOF) was investigated. The effect of pre-slaughter stress on the development of WOF is a relatively new area...

Cite
Brøndum J, Byrne DV, Bak LS, et al. Warmed-over flavour in porcine meat - a combined spectroscopic, sensory and chemometric study. Meat Sci. 2000;54(1):83-95doi: 10.1016/s0309-1740(99)00085-6.
Brøndum, J., Byrne, D. V., Bak, L. S., Bertelsen, G., & Engelsen, S. B. (2000). Warmed-over flavour in porcine meat - a combined spectroscopic, sensory and chemometric study. Meat science, 54(1), 83-95. https://doi.org/10.1016/s0309-1740(99)00085-6
Brøndum, J, et al. "Warmed-over flavour in porcine meat - a combined spectroscopic, sensory and chemometric study." Meat science vol. 54,1 (2000): 83-95. doi: https://doi.org/10.1016/s0309-1740(99)00085-6
Brøndum J, Byrne DV, Bak LS, Bertelsen G, Engelsen SB. Warmed-over flavour in porcine meat - a combined spectroscopic, sensory and chemometric study. Meat Sci. 2000 Jan;54(1):83-95. doi: 10.1016/s0309-1740(99)00085-6. PMID: 22063716.
Copy Download .nbib Format: NLM
Tumor mutational burden and purity adjustment before and after treatment with temozolomide in 27 paired samples of glioblastoma: a prospective study.

Molecular oncology

Schou Nørøxe D, Flynn A, Westmose Yde C, Østrup O, Cilius Nielsen F, Skjøth-Rasmussen J, Brennum J, Hamerlik P, Weischenfeldt J, Skovgaard Poulsen H, Lassen U.
PMID: 34018316
Mol Oncol. 2022 Jan;16(1):206-218. doi: 10.1002/1878-0261.13015. Epub 2021 Jun 25.

Treatment of glioblastoma (GBM) remains a challenging task, with limited treatment options, none offering a cure. Immune therapy has proven effective across different cancers with remarkable response rates. Tumor mutational burden (TMB) is a marker of response, but technical...

Cite
Schou Nørøxe D, Flynn A, Westmose Yde C, et al. Tumor mutational burden and purity adjustment before and after treatment with temozolomide in 27 paired samples of glioblastoma: a prospective study. Mol Oncol. 2021;16(1):206-218doi: 10.1002/1878-0261.13015.
Schou Nørøxe, D., Flynn, A., Westmose Yde, C., Østrup, O., Cilius Nielsen, F., Skjøth-Rasmussen, J., Brennum, J., Hamerlik, P., Weischenfeldt, J., Skovgaard Poulsen, H., & Lassen, U. (2022). Tumor mutational burden and purity adjustment before and after treatment with temozolomide in 27 paired samples of glioblastoma: a prospective study. Molecular oncology, 16(1), 206-218. https://doi.org/10.1002/1878-0261.13015
Schou Nørøxe, Dorte, et al. "Tumor mutational burden and purity adjustment before and after treatment with temozolomide in 27 paired samples of glioblastoma: a prospective study." Molecular oncology vol. 16,1 (2022): 206-218. doi: https://doi.org/10.1002/1878-0261.13015
Schou Nørøxe D, Flynn A, Westmose Yde C, Østrup O, Cilius Nielsen F, Skjøth-Rasmussen J, Brennum J, Hamerlik P, Weischenfeldt J, Skovgaard Poulsen H, Lassen U. Tumor mutational burden and purity adjustment before and after treatment with temozolomide in 27 paired samples of glioblastoma: a prospective study. Mol Oncol. 2022 Jan;16(1):206-218. doi: 10.1002/1878-0261.13015. Epub 2021 Jun 25. PMID: 34018316.
Copy Download .nbib Format: NLM
Tumor mutational burden and purity adjustment before and after treatment with temozolomide in 27 paired samples of glioblastoma: a prospective study.

Molecular oncology

Schou Nørøxe D, Flynn A, Westmose Yde C, Østrup O, Cilius Nielsen F, Skjøth-Rasmussen J, Brennum J, Hamerlik P, Weischenfeldt J, Skovgaard Poulsen H, Lassen U.
PMID: 34018316
Mol Oncol. 2021 May 20; doi: 10.1002/1878-0261.13015. Epub 2021 May 20.

Treatment of glioblastoma (GBM) remains a challenging task, with limited treatment options, none offering a cure. Immune therapy has proven effective across different cancers with remarkable response rates. Tumor mutational burden (TMB) is a marker of response, but technical...

Cite
Schou Nørøxe D, Flynn A, Westmose Yde C, et al. Tumor mutational burden and purity adjustment before and after treatment with temozolomide in 27 paired samples of glioblastoma: a prospective study. Mol Oncol. 2021;doi: 10.1002/1878-0261.13015.
Schou Nørøxe, D., Flynn, A., Westmose Yde, C., Østrup, O., Cilius Nielsen, F., Skjøth-Rasmussen, J., Brennum, J., Hamerlik, P., Weischenfeldt, J., Skovgaard Poulsen, H., & Lassen, U. (2021). Tumor mutational burden and purity adjustment before and after treatment with temozolomide in 27 paired samples of glioblastoma: a prospective study. Molecular oncology, . https://doi.org/10.1002/1878-0261.13015
Schou Nørøxe, Dorte, et al. "Tumor mutational burden and purity adjustment before and after treatment with temozolomide in 27 paired samples of glioblastoma: a prospective study." Molecular oncology vol. (2021). doi: https://doi.org/10.1002/1878-0261.13015
Schou Nørøxe D, Flynn A, Westmose Yde C, Østrup O, Cilius Nielsen F, Skjøth-Rasmussen J, Brennum J, Hamerlik P, Weischenfeldt J, Skovgaard Poulsen H, Lassen U. Tumor mutational burden and purity adjustment before and after treatment with temozolomide in 27 paired samples of glioblastoma: a prospective study. Mol Oncol. 2021 May 20; doi: 10.1002/1878-0261.13015. Epub 2021 May 20. PMID: 34018316.
Copy Download .nbib Format: NLM
Multifunctional Water Sensors for pH, ORP, and Conductivity Using Only Microfabricated Platinum Electrodes.

Sensors (Basel, Switzerland)

Lin WC, Brondum K, Monroe CW, Burns MA.
PMID: 28753913
Sensors (Basel). 2017 Jul 19;17(7). doi: 10.3390/s17071655.

Monitoring of the pH, oxidation-reduction-potential (ORP), and conductivity of aqueous samples is typically performed using multiple sensors. To minimize the size and cost of these sensors for practical applications, we have investigated the use of a single sensor constructed...

Cite
Lin WC, Brondum K, Monroe CW, et al. Multifunctional Water Sensors for pH, ORP, and Conductivity Using Only Microfabricated Platinum Electrodes. Sensors (Basel). 2017;17(7)doi: 10.3390/s17071655.
Lin, W. C., Brondum, K., Monroe, C. W., & Burns, M. A. (2017). Multifunctional Water Sensors for pH, ORP, and Conductivity Using Only Microfabricated Platinum Electrodes. Sensors (Basel, Switzerland), 17(7), . https://doi.org/10.3390/s17071655
Lin, Wen-Chi, et al. "Multifunctional Water Sensors for pH, ORP, and Conductivity Using Only Microfabricated Platinum Electrodes." Sensors (Basel, Switzerland) vol. 17,7 (2017). doi: https://doi.org/10.3390/s17071655
Lin WC, Brondum K, Monroe CW, Burns MA. Multifunctional Water Sensors for pH, ORP, and Conductivity Using Only Microfabricated Platinum Electrodes. Sensors (Basel). 2017 Jul 19;17(7). doi: 10.3390/s17071655. PMID: 28753913; PMCID: PMC5539692.
Copy Download .nbib Format: NLM
United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU).

United European gastroenterology journal

Löhr JM, Dominguez-Munoz E, Rosendahl J, Besselink M, Mayerle J, Lerch MM, Haas S, Akisik F, Kartalis N, Iglesias-Garcia J, Keller J, Boermeester M, Werner J, Dumonceau JM, Fockens P, Drewes A, Ceyhan G, Lindkvist B, Drenth J, Ewald N, Hardt P, de Madaria E, Witt H, Schneider A, Manfredi R, Brøndum FJ, Rudolf S, Bollen T, Bruno M.
PMID: 28344786
United European Gastroenterol J. 2017 Mar;5(2):153-199. doi: 10.1177/2050640616684695. Epub 2017 Jan 16.

BACKGROUND: There have been substantial improvements in the management of chronic pancreatitis, leading to the publication of several national guidelines during recent years. In collaboration with United European Gastroenterology, the working group on 'Harmonizing diagnosis and treatment of chronic...

Cite
Löhr JM, Dominguez-Munoz E, Rosendahl J, et al. United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU). United European Gastroenterol J. 2017;5(2):153-199doi: 10.1177/2050640616684695.
Löhr, J. M., Dominguez-Munoz, E., Rosendahl, J., Besselink, M., Mayerle, J., Lerch, M. M., Haas, S., Akisik, F., Kartalis, N., Iglesias-Garcia, J., Keller, J., Boermeester, M., Werner, J., Dumonceau, J. M., Fockens, P., Drewes, A., Ceyhan, G., Lindkvist, B., Drenth, J., Ewald, N., Hardt, P., de Madaria, E., Witt, H., Schneider, A., Manfredi, R., Brøndum, F. J., Rudolf, S., Bollen, T., Bruno, M. (2017). United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU). United European gastroenterology journal, 5(2), 153-199. https://doi.org/10.1177/2050640616684695
Löhr, J Matthias, et al. "United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU)." United European gastroenterology journal vol. 5,2 (2017): 153-199. doi: https://doi.org/10.1177/2050640616684695
Löhr JM, Dominguez-Munoz E, Rosendahl J, Besselink M, Mayerle J, Lerch MM, Haas S, Akisik F, Kartalis N, Iglesias-Garcia J, Keller J, Boermeester M, Werner J, Dumonceau JM, Fockens P, Drewes A, Ceyhan G, Lindkvist B, Drenth J, Ewald N, Hardt P, de Madaria E, Witt H, Schneider A, Manfredi R, Brøndum FJ, Rudolf S, Bollen T, Bruno M. United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU). United European Gastroenterol J. 2017 Mar;5(2):153-199. doi: 10.1177/2050640616684695. Epub 2017 Jan 16. PMID: 28344786; PMCID: PMC5349368.
Copy Download .nbib Format: NLM
Ethical triage during the COVID-19 pandemic: a toolkit for neurosurgical resource allocation.

Acta neurochirurgica

Hulsbergen AFC, Eijkholt MM, Balak N, Brennum J, Bolger C, Bohrer AM, Feldman Z, Holsgrove D, Kitchen N, Mathiesen TI, Moojen WA, Samprón N, Sames M, Sandvik U, Tisell M, Broekman MLD.
PMID: 32405671
Acta Neurochir (Wien). 2020 Jul;162(7):1485-1490. doi: 10.1007/s00701-020-04375-w. Epub 2020 May 14.

BACKGROUND: The COVID-19 pandemic confronts healthcare workers, including neurosurgeons, with difficult choices regarding which patients to treat.METHODS: In order to assist ethical triage, this article gives an overview of the main considerations and ethical principles relevant when allocating resources...

Cite
Hulsbergen AFC, Eijkholt MM, Balak N, et al. Ethical triage during the COVID-19 pandemic: a toolkit for neurosurgical resource allocation. Acta Neurochir (Wien). 2020;162(7):1485-1490doi: 10.1007/s00701-020-04375-w.
Hulsbergen, A. F. C., Eijkholt, M. M., Balak, N., Brennum, J., Bolger, C., Bohrer, A. M., Feldman, Z., Holsgrove, D., Kitchen, N., Mathiesen, T. I., Moojen, W. A., Samprón, N., Sames, M., Sandvik, U., Tisell, M., & Broekman, M. L. D. (2020). Ethical triage during the COVID-19 pandemic: a toolkit for neurosurgical resource allocation. Acta neurochirurgica, 162(7), 1485-1490. https://doi.org/10.1007/s00701-020-04375-w
Hulsbergen, Alexander F C, et al. "Ethical triage during the COVID-19 pandemic: a toolkit for neurosurgical resource allocation." Acta neurochirurgica vol. 162,7 (2020): 1485-1490. doi: https://doi.org/10.1007/s00701-020-04375-w
Hulsbergen AFC, Eijkholt MM, Balak N, Brennum J, Bolger C, Bohrer AM, Feldman Z, Holsgrove D, Kitchen N, Mathiesen TI, Moojen WA, Samprón N, Sames M, Sandvik U, Tisell M, Broekman MLD. Ethical triage during the COVID-19 pandemic: a toolkit for neurosurgical resource allocation. Acta Neurochir (Wien). 2020 Jul;162(7):1485-1490. doi: 10.1007/s00701-020-04375-w. Epub 2020 May 14. PMID: 32405671; PMCID: PMC7220806.
Copy Download .nbib Format: NLM
A comparative study of standardized quantitative and visual assessment for predicting tumor volume and outcome in newly diagnosed diffuse large B-cell lymphoma staged with 18F-FDG PET/CT.

EJNMMI research

Gormsen LC, Vendelbo MH, Pedersen MA, Haraldsen A, Hjorthaug K, Bogsrud TV, Petersen LJ, Jensen KJ, Brøndum R, El-Galaly TC.
PMID: 31054023
EJNMMI Res. 2019 May 03;9(1):36. doi: 10.1186/s13550-019-0503-z.

BACKGROUND: Semi-automated quantitative measurement of metabolic tumor volume (MTV) for prognosis in diffuse large B-Cell lymphoma (DLBCL) has gained considerable interest lately. However, simple tumor volume measures may be inadequate for assessment of prognosis in DLBCL as other characteristics...

Cite
Gormsen LC, Vendelbo MH, Pedersen MA, et al. A comparative study of standardized quantitative and visual assessment for predicting tumor volume and outcome in newly diagnosed diffuse large B-cell lymphoma staged with 18F-FDG PET/CT. EJNMMI Res. 2019;9(1):36doi: 10.1186/s13550-019-0503-z.
Gormsen, L. C., Vendelbo, M. H., Pedersen, M. A., Haraldsen, A., Hjorthaug, K., Bogsrud, T. V., Petersen, L. J., Jensen, K. J., Brøndum, R., & El-Galaly, T. C. (2019). A comparative study of standardized quantitative and visual assessment for predicting tumor volume and outcome in newly diagnosed diffuse large B-cell lymphoma staged with 18F-FDG PET/CT. EJNMMI research, 9(1), 36. https://doi.org/10.1186/s13550-019-0503-z
Gormsen, Lars C, et al. "A comparative study of standardized quantitative and visual assessment for predicting tumor volume and outcome in newly diagnosed diffuse large B-cell lymphoma staged with 18F-FDG PET/CT." EJNMMI research vol. 9,1 (2019): 36. doi: https://doi.org/10.1186/s13550-019-0503-z
Gormsen LC, Vendelbo MH, Pedersen MA, Haraldsen A, Hjorthaug K, Bogsrud TV, Petersen LJ, Jensen KJ, Brøndum R, El-Galaly TC. A comparative study of standardized quantitative and visual assessment for predicting tumor volume and outcome in newly diagnosed diffuse large B-cell lymphoma staged with 18F-FDG PET/CT. EJNMMI Res. 2019 May 03;9(1):36. doi: 10.1186/s13550-019-0503-z. PMID: 31054023; PMCID: PMC6499846.
Copy Download .nbib Format: NLM
Revisiting EEG as part of the multidisciplinary approach to post-cardiac arrest care and prognostication: A review.

Resuscitation plus

Bronder J, Cho SM, Geocadin RG, Ritzl EK.
PMID: 34988537
Resusc Plus. 2021 Dec 16;9:100189. doi: 10.1016/j.resplu.2021.100189. eCollection 2022 Mar.

Since the 1960s, EEG has been used to assess the neurologic function of patients in the hours and days after cardiac arrest. Accurate and reliable prognostication after cardiac arrest is vital for tailoring aggressive patient care for those with...

Cite
Bronder J, Cho SM, Geocadin RG, et al. Revisiting EEG as part of the multidisciplinary approach to post-cardiac arrest care and prognostication: A review. Resusc Plus. 2021;9:100189doi: 10.1016/j.resplu.2021.100189.
Bronder, J., Cho, S. M., Geocadin, R. G., & Ritzl, E. K. (2022). Revisiting EEG as part of the multidisciplinary approach to post-cardiac arrest care and prognostication: A review. Resuscitation plus, 9100189. https://doi.org/10.1016/j.resplu.2021.100189
Bronder, Jay, et al. "Revisiting EEG as part of the multidisciplinary approach to post-cardiac arrest care and prognostication: A review." Resuscitation plus vol. 9 (2022): 100189. doi: https://doi.org/10.1016/j.resplu.2021.100189
Bronder J, Cho SM, Geocadin RG, Ritzl EK. Revisiting EEG as part of the multidisciplinary approach to post-cardiac arrest care and prognostication: A review. Resusc Plus. 2021 Dec 16;9:100189. doi: 10.1016/j.resplu.2021.100189. eCollection 2022 Mar. PMID: 34988537; PMCID: PMC8693464.
Copy Download .nbib Format: NLM
Revisiting EEG as part of the multidisciplinary approach to post-cardiac arrest care and prognostication: A review.

Resuscitation plus

Bronder J, Cho SM, Geocadin RG, Ritzl EK.
PMID: 34988537
Resusc Plus. 2021 Dec 16;9:100189. doi: 10.1016/j.resplu.2021.100189. eCollection 2022 Mar.

Since the 1960s, EEG has been used to assess the neurologic function of patients in the hours and days after cardiac arrest. Accurate and reliable prognostication after cardiac arrest is vital for tailoring aggressive patient care for those with...

Cite
Bronder J, Cho SM, Geocadin RG, et al. Revisiting EEG as part of the multidisciplinary approach to post-cardiac arrest care and prognostication: A review. Resusc Plus. 2021;9:100189doi: 10.1016/j.resplu.2021.100189.
Bronder, J., Cho, S. M., Geocadin, R. G., & Ritzl, E. K. (2022). Revisiting EEG as part of the multidisciplinary approach to post-cardiac arrest care and prognostication: A review. Resuscitation plus, 9100189. https://doi.org/10.1016/j.resplu.2021.100189
Bronder, Jay, et al. "Revisiting EEG as part of the multidisciplinary approach to post-cardiac arrest care and prognostication: A review." Resuscitation plus vol. 9 (2022): 100189. doi: https://doi.org/10.1016/j.resplu.2021.100189
Bronder J, Cho SM, Geocadin RG, Ritzl EK. Revisiting EEG as part of the multidisciplinary approach to post-cardiac arrest care and prognostication: A review. Resusc Plus. 2021 Dec 16;9:100189. doi: 10.1016/j.resplu.2021.100189. eCollection 2022 Mar. PMID: 34988537; PMCID: PMC8693464.
Copy Download .nbib Format: NLM
Azithromycin and hydroxychloroquine in hospitalised patients with confirmed COVID-19: a randomised double-blinded placebo-controlled trial.

The European respiratory journal

Sivapalan P, Ulrik CS, Lapperre TS, Bojesen RD, Eklöf J, Browatzki A, Wilcke JT, Gottlieb V, Håkansson KEJ, Tidemandsen C, Tupper O, Meteran H, Bergsøe C, Brøndum E, Bødtger U, Bech Rasmussen D, Graff Jensen S, Pedersen L, Jordan A, Priemé H, Søborg C, Steffensen IE, Høgsberg D, Klausen TW, Frydland MS, Lange P, Sverrild A, Ghanizada M, Knop FK, Biering-Sørensen T, Lundgren JD, Jensen JS.
PMID: 34083403
Eur Respir J. 2022 Jan 06;59(1). doi: 10.1183/13993003.00752-2021. Print 2022 Jan.

BACKGROUND: Combining the antibiotic azithromycin and hydroxychloroquine induces airway immunomodulatory effects, with the latter also having METHODS: Placebo-controlled double-blind randomised multicentre trial. Patients aged ≥18 years, admitted to hospital for ≤48 h (not intensive care) with a positive severe...

Cite
Sivapalan P, Ulrik CS, Lapperre TS, et al. Azithromycin and hydroxychloroquine in hospitalised patients with confirmed COVID-19: a randomised double-blinded placebo-controlled trial. Eur Respir J. 2022;59(1)doi: 10.1183/13993003.00752-2021.
Sivapalan, P., Ulrik, C. S., Lapperre, T. S., Bojesen, R. D., Eklöf, J., Browatzki, A., Wilcke, J. T., Gottlieb, V., Håkansson, K. E. J., Tidemandsen, C., Tupper, O., Meteran, H., Bergsøe, C., Brøndum, E., Bødtger, U., Bech Rasmussen, D., Graff Jensen, S., Pedersen, L., Jordan, A., Priemé, H., Søborg, C., Steffensen, I. E., Høgsberg, D., Klausen, T. W., Frydland, M. S., Lange, P., Sverrild, A., Ghanizada, M., Knop, F. K., Biering-Sørensen, T., Lundgren, J. D., Jensen, J. S. (2022). Azithromycin and hydroxychloroquine in hospitalised patients with confirmed COVID-19: a randomised double-blinded placebo-controlled trial. The European respiratory journal, 59(1), . https://doi.org/10.1183/13993003.00752-2021
Sivapalan, Pradeesh, et al. "Azithromycin and hydroxychloroquine in hospitalised patients with confirmed COVID-19: a randomised double-blinded placebo-controlled trial." The European respiratory journal vol. 59,1 (2022). doi: https://doi.org/10.1183/13993003.00752-2021
Sivapalan P, Ulrik CS, Lapperre TS, Bojesen RD, Eklöf J, Browatzki A, Wilcke JT, Gottlieb V, Håkansson KEJ, Tidemandsen C, Tupper O, Meteran H, Bergsøe C, Brøndum E, Bødtger U, Bech Rasmussen D, Graff Jensen S, Pedersen L, Jordan A, Priemé H, Søborg C, Steffensen IE, Høgsberg D, Klausen TW, Frydland MS, Lange P, Sverrild A, Ghanizada M, Knop FK, Biering-Sørensen T, Lundgren JD, Jensen JS. Azithromycin and hydroxychloroquine in hospitalised patients with confirmed COVID-19: a randomised double-blinded placebo-controlled trial. Eur Respir J. 2022 Jan 06;59(1). doi: 10.1183/13993003.00752-2021. Print 2022 Jan. PMID: 34083403; PMCID: PMC8186006.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 29 entries